References
- van de Schans SA, Janssen-Heijnen ML, Nijziel MR, Steyerberg EW, van Spronsen DJ. Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting. Haematologica. 2010;95(9):1503-9. doi: 10.3324/haematol.2009.021113. PMC2930951.
- Hoster E, Rosenwald A, Berger F, Bernd HW, Hartmann S, Loddenkemper C, et al. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network. J Clin Oncol. 2016;34(12):1386-94. doi: 10.1200/jco.2015.63.8387. PMC26926679.
- Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720-48. doi: 10.1038/s41375-022-01620-2. PMC9214472
- Szumera-Ciećkiewicz A, Gałązka K, Szpor J, Rymkiewicz G, Jesionek-Kupnicka D, Gruchała A, et al. Distribution of lymphomas in Poland according to World Health Organization classification: analysis of 11718 cases from National Histopathological Lymphoma Register project - the Polish Lymphoma Research Group study. Int J Clin Exp Pathol. 2014;7(6):3280-6. doi: PMC4097276.
- Sehn LH, Salles G. Diffuse Large B-Cell Lymphoma. N Engl J Med. 2021;384(9):842-58. doi: 10.1056/NEJMra2027612. PMC8377611.
- Padala SA, Kallam A. Diffuse Large B-Cell Lymphoma. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC.; 2025.
- Ollila TA, Olszewski AJ. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence. Curr Treat Options Oncol. 2018;19(8):38. doi: 10.1007/s11864-018-0555-8. PMC6294323.
- Jerkeman M, Aurer I, Campo E, Cheah CY, Clark J, Doorduijn J, et al. EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma. Hemasphere. 2025;9(10):e70233. doi: 10.1002/hem3.70233. PMC12541557.
- Lynch DT, Koya S, Dogga S, Kumar A. Mantle Cell Lymphoma. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC.; 2025.
- Khanlari M, Mo H, Kim DH, Sakhdari A, Young KH, Jain P, et al. Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features. Am J Surg Pathol. 2023;47(8):849-58. doi: 10.1097/pas.0000000000002068. PMC10348620.
- Lee W, Shin E, Kim BH, Kim H. Inconsistency associated with SOX11 immunohistochemistry in mantle cell lymphoma: a meta-analysis. Journal of Hematopathology. 2019;12(3):109-19. doi: 10.1007/s12308-019-00361-z.
- Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v116-25. doi: 10.1093/annonc/mdv304. PMC26314773.
- Sander B. Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers. Seminars in Diagnostic Pathology. 2011;28(3):245-55. doi: 10.1053/j.semdp.2011.02.010. PMC21850989.
- Ngeow JYY, Quek RHH, Ng DCE, Hee SW, Tao M, Lim LC, et al. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma. Ann Oncol. 2009;20(9):1543-7. doi: 10.1093/annonc/mdp030. PMC19474116.
- Nguyen NC, Kaushik A, Wolverson MK, Osman MM. Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study. Acta Oncol. 2011;50(5):670-7. doi: 10.3109/0284186x.2010.550933. PMC21247262.
- Ok CY, Xu-Monette ZY, Tzankov A, O’Malley DP, Montes-Moreno S, Visco C, et al. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer. 2014;120(12):1818-29. doi: 10.1002/cncr.28664. PMC24648050.
- Gualco G, Weiss LM, Harrington WJ, Jr., Bacchi CE. BCL6, MUM1, and CD10 expression in mantle cell lymphoma. Appl Immunohistochem Mol Morphol. 2010;18(2):103-8. doi: 10.1097/PAI.0b013e3181bb9edf. PMC2828511.